2025-03-18 2026-03-31 2026-03-31 false 16323003 THE HERBANISTA LIMITED 2026-08-13 85422 false iso4217:GBP xbrli:pure 16323003 2025-03-17 16323003 2026-03-31 16323003 2025-03-18 2026-03-31 16323003 2025-03-16 16323003 2025-03-17 16323003 2025-03-17 2025-03-17 16323003 bus:SmallEntities 2025-03-18 2026-03-31 16323003 bus:AuditExempt-NoAccountantsReport 2025-03-18 2026-03-31 16323003 bus:FullAccounts 2025-03-18 2026-03-31 16323003 bus:PrivateLimitedCompanyLtd 2025-03-18 2026-03-31 16323003 core:WithinOneYear 2026-03-31 16323003 core:AfterOneYear 2026-03-31 16323003 core:WithinOneYear 2025-03-17 16323003 core:AfterOneYear 2025-03-17 16323003 core:ShareCapital 2026-03-31 16323003 core:SharePremium 2026-03-31 16323003 core:RevaluationReserve 2026-03-31 16323003 core:OtherReservesSubtotal 2026-03-31 16323003 core:RetainedEarningsAccumulatedLosses 2026-03-31 16323003 core:ShareCapital 2025-03-17 16323003 core:SharePremium 2025-03-17 16323003 core:RevaluationReserve 2025-03-17 16323003 core:OtherReservesSubtotal 2025-03-17 16323003 core:RetainedEarningsAccumulatedLosses 2025-03-17 16323003 core:LandBuildings 2026-03-31 16323003 core:PlantMachinery 2026-03-31 16323003 core:Vehicles 2026-03-31 16323003 core:FurnitureFittings 2026-03-31 16323003 core:OfficeEquipment 2026-03-31 16323003 core:NetGoodwill 2026-03-31 16323003 core:IntangibleAssetsOtherThanGoodwill 2026-03-31 16323003 core:ListedExchangeTraded 2026-03-31 16323003 core:UnlistedNon-exchangeTraded 2026-03-31 16323003 core:LandBuildings 2025-03-17 16323003 core:PlantMachinery 2025-03-17 16323003 core:Vehicles 2025-03-17 16323003 core:FurnitureFittings 2025-03-17 16323003 core:OfficeEquipment 2025-03-17 16323003 core:NetGoodwill 2025-03-17 16323003 core:IntangibleAssetsOtherThanGoodwill 2025-03-17 16323003 core:ListedExchangeTraded 2025-03-17 16323003 core:UnlistedNon-exchangeTraded 2025-03-17 16323003 core:LandBuildings 2025-03-18 2026-03-31 16323003 core:PlantMachinery 2025-03-18 2026-03-31 16323003 core:Vehicles 2025-03-18 2026-03-31 16323003 core:FurnitureFittings 2025-03-18 2026-03-31 16323003 core:OfficeEquipment 2025-03-18 2026-03-31 16323003 core:NetGoodwill 2025-03-18 2026-03-31 16323003 core:IntangibleAssetsOtherThanGoodwill 2025-03-18 2026-03-31 16323003 core:ListedExchangeTraded 2025-03-18 2026-03-31 16323003 core:UnlistedNon-exchangeTraded 2025-03-18 2026-03-31 16323003 core:MoreThanFiveYears 2025-03-18 2026-03-31 16323003 core:Non-currentFinancialInstruments 2026-03-31 16323003 core:Non-currentFinancialInstruments 2025-03-17 16323003 dpl:CostSales 2025-03-18 2026-03-31 16323003 dpl:DistributionCosts 2025-03-18 2026-03-31 16323003 core:LandBuildings 2025-03-18 2026-03-31 16323003 core:PlantMachinery 2025-03-18 2026-03-31 16323003 core:Vehicles 2025-03-18 2026-03-31 16323003 core:FurnitureFittings 2025-03-18 2026-03-31 16323003 core:OfficeEquipment 2025-03-18 2026-03-31 16323003 dpl:AdministrativeExpenses 2025-03-18 2026-03-31 16323003 core:NetGoodwill 2025-03-18 2026-03-31 16323003 core:IntangibleAssetsOtherThanGoodwill 2025-03-18 2026-03-31 16323003 dpl:GroupUndertakings 2025-03-18 2026-03-31 16323003 dpl:ParticipatingInterests 2025-03-18 2026-03-31 16323003 dpl:GroupUndertakings core:ListedExchangeTraded 2025-03-18 2026-03-31 16323003 core:ListedExchangeTraded 2025-03-18 2026-03-31 16323003 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2025-03-18 2026-03-31 16323003 core:UnlistedNon-exchangeTraded 2025-03-18 2026-03-31 16323003 dpl:CostSales 2025-03-17 2025-03-17 16323003 dpl:DistributionCosts 2025-03-17 2025-03-17 16323003 core:LandBuildings 2025-03-17 2025-03-17 16323003 core:PlantMachinery 2025-03-17 2025-03-17 16323003 core:Vehicles 2025-03-17 2025-03-17 16323003 core:FurnitureFittings 2025-03-17 2025-03-17 16323003 core:OfficeEquipment 2025-03-17 2025-03-17 16323003 dpl:AdministrativeExpenses 2025-03-17 2025-03-17 16323003 core:NetGoodwill 2025-03-17 2025-03-17 16323003 core:IntangibleAssetsOtherThanGoodwill 2025-03-17 2025-03-17 16323003 dpl:GroupUndertakings 2025-03-17 2025-03-17 16323003 dpl:ParticipatingInterests 2025-03-17 2025-03-17 16323003 dpl:GroupUndertakings core:ListedExchangeTraded 2025-03-17 2025-03-17 16323003 core:ListedExchangeTraded 2025-03-17 2025-03-17 16323003 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2025-03-17 2025-03-17 16323003 core:UnlistedNon-exchangeTraded 2025-03-17 2025-03-17 16323003 core:NetGoodwill 2026-03-31 16323003 core:IntangibleAssetsOtherThanGoodwill 2026-03-31 16323003 core:LandBuildings 2026-03-31 16323003 core:PlantMachinery 2026-03-31 16323003 core:Vehicles 2026-03-31 16323003 core:FurnitureFittings 2026-03-31 16323003 core:OfficeEquipment 2026-03-31 16323003 core:AfterOneYear 2026-03-31 16323003 core:WithinOneYear 2026-03-31 16323003 core:ListedExchangeTraded 2026-03-31 16323003 core:UnlistedNon-exchangeTraded 2026-03-31 16323003 core:ShareCapital 2026-03-31 16323003 core:SharePremium 2026-03-31 16323003 core:RevaluationReserve 2026-03-31 16323003 core:OtherReservesSubtotal 2026-03-31 16323003 core:RetainedEarningsAccumulatedLosses 2026-03-31 16323003 core:NetGoodwill 2025-03-17 16323003 core:IntangibleAssetsOtherThanGoodwill 2025-03-17 16323003 core:LandBuildings 2025-03-17 16323003 core:PlantMachinery 2025-03-17 16323003 core:Vehicles 2025-03-17 16323003 core:FurnitureFittings 2025-03-17 16323003 core:OfficeEquipment 2025-03-17 16323003 core:AfterOneYear 2025-03-17 16323003 core:WithinOneYear 2025-03-17 16323003 core:ListedExchangeTraded 2025-03-17 16323003 core:UnlistedNon-exchangeTraded 2025-03-17 16323003 core:ShareCapital 2025-03-17 16323003 core:SharePremium 2025-03-17 16323003 core:RevaluationReserve 2025-03-17 16323003 core:OtherReservesSubtotal 2025-03-17 16323003 core:RetainedEarningsAccumulatedLosses 2025-03-17 16323003 core:NetGoodwill 2025-03-16 16323003 core:IntangibleAssetsOtherThanGoodwill 2025-03-16 16323003 core:LandBuildings 2025-03-16 16323003 core:PlantMachinery 2025-03-16 16323003 core:Vehicles 2025-03-16 16323003 core:FurnitureFittings 2025-03-16 16323003 core:OfficeEquipment 2025-03-16 16323003 core:AfterOneYear 2025-03-16 16323003 core:WithinOneYear 2025-03-16 16323003 core:ListedExchangeTraded 2025-03-16 16323003 core:UnlistedNon-exchangeTraded 2025-03-16 16323003 core:ShareCapital 2025-03-16 16323003 core:SharePremium 2025-03-16 16323003 core:RevaluationReserve 2025-03-16 16323003 core:OtherReservesSubtotal 2025-03-16 16323003 core:RetainedEarningsAccumulatedLosses 2025-03-16 16323003 core:AfterOneYear 2025-03-18 2026-03-31 16323003 core:WithinOneYear 2025-03-18 2026-03-31 16323003 core:Non-currentFinancialInstruments core:CostValuation 2025-03-18 2026-03-31 16323003 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-03-18 2026-03-31 16323003 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-03-18 2026-03-31 16323003 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-03-18 2026-03-31 16323003 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-03-18 2026-03-31 16323003 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-03-18 2026-03-31 16323003 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-03-18 2026-03-31 16323003 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-03-18 2026-03-31 16323003 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-03-18 2026-03-31 16323003 core:Non-currentFinancialInstruments core:CostValuation 2026-03-31 16323003 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2026-03-31 16323003 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2026-03-31 16323003 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2026-03-31 16323003 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2026-03-31 16323003 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2026-03-31 16323003 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2026-03-31 16323003 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2026-03-31 16323003 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2026-03-31 16323003 core:Non-currentFinancialInstruments core:CostValuation 2025-03-17 16323003 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-03-17 16323003 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-03-17 16323003 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-03-17 16323003 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-03-17 16323003 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-03-17 16323003 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-03-17 16323003 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-03-17 16323003 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-03-17 16323003 bus:Director1 2025-03-18 2026-03-31

THE HERBANISTA LIMITED

Registered Number
16323003
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2026

THE HERBANISTA LIMITED
Company Information
for the period from 18 March 2025 to 31 March 2026

Director | Gabrielle Forrester

Registered Address | 179 Park Lane
| Poynton
| SK12 1RH

Registered Number | 16323003 (England and Wales)

THE HERBANISTA LIMITED
Balance Sheet as at
31 March 2026

| Notes | 2026
--- | --- | ---
|  | £ |  | £
Current assets |  |  |  |
Debtors |  | 1,213 |  |
Cash at bank and on hand |  | 1,085 |  |
|  | 2,298 |  |
Creditors amounts falling due within one year | 3 | (2,286) |  |
Net current assets (liabilities) |  |  |  | 12
Total assets less current liabilities |  |  |  | 12
Net assets |  |  |  | 12
Capital and reserves |  |  |  |
Called up share capital |  |  |  | 100
Profit and loss account |  |  |  | (88)
Shareholders' funds |  |  |  | 12

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 13 August 2026, and are signed on its behalf by:
Gabrielle Forrester Director Registered Company No. 16323003

THE HERBANISTA LIMITED
Notes to the Financial Statements
for the period ended 31 March 2026

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Judgements and key sources of estimation uncertainty
--- | ---
| In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

| Revenue from rendering of services
--- | ---
| Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

2. | Average number of employees
--- | ---

|  | 2026
| Average number of employees during the year | 1

3. | Creditors: amounts due within one year
--- | ---

|  | 2026
--- | --- | ---
|  | £
| Taxation and social security | 1,786
| Accrued liabilities and deferred income | 500
| Total | 2,286

| Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

4. | Provisions for liabilities
--- | ---
| Provisions are made where an event has taken place that gives the company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of going the amount of the obligation. Provisions are charged as an expense to the profit and loss account in the year that the company becomes aware of the obligation and are measured at the best estimate at balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties. When payments are eventually made, they are charged to the provision carried in the balance sheet.